You may envision Vevey, Switzerland-based Nestlé as a global food giant, but on its Web site, the company refers to itself as “the world’s leading nutrition, health, and wellness company.”
On May 24, Nestlé Health Science S.A. announced that it had agreed to acquire Prometheus Laboratories Inc., a San Diego-based company that specializes in diagnostics and in-licensed specialty pharmaceuticals in gastroenterology and oncology. The company focuses on conditions such as inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis.
